TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
Apr 2003 - Clin. Cancer Res.; 9(4):1078-0432 [PMID:12684428]
[Schlienger K] [Chu CS] [Woo EY] [Rivers PM] [Toll AJ] [Hudson B] [Maus MV] [Riley JL] [Choi Y] [Coukos G] [Kaiser LR] [Rubin SC] [Levine BL] [Carroll RG] [June CH]